Parkinson's Foundation Announces Inaugural "A Day to Reach Further"

2023-09-18
– Day of Giving on Tuesday, Sept. 19
MIAMI and NEW YORK, Sept. 18, 2023 /PRNewswire/ -- The Parkinson's Foundation today announced the launch of its inaugural day of giving, "A Day to Reach Further," to encourage communities to raise awareness of Parkinson's disease (PD) while raising funds to accelerate PD research, improve care and increase access to quality-of-life programs. The 24-hour event aims to support the Reach Further campaign's four-year fundraising goal of $30 million. More than half of the goal has been raised in the past two years.
"Having the entire Parkinson's community participate in "A Day to Reach Further" will make for an amazing collective effort toward making life better for people living with the disease and their loved ones," said Parkinson's Foundation President and CEO John L. Lehr.
Parkinson's is now the fastest-growing neurological condition in the world. Each year, 90,000 people in the U.S. are newly diagnosed with PD, and the number of people living with PD across the country is expected to rise to 1.2 million by 2030.
Those looking to support the Foundation's mission today will have the opportunity to support the philanthropic effort for research advancement by making a campaign donation, starting a Facebook fundraiser, and helping spread the word on social media and in local communities. Supporters who participate in "A Day to Reach Further" will be thanked with a special invitation to future research webinars.
As part of the celebration, Rune Labs, provider of StrivePD, will generously match all gifts made up to $10,000 today. To make a gift, visit Parkinson.org/ReachFurtherDay.
About the Parkinson's Foundation
The Parkinson's Foundation makes life better for people with Parkinson's disease by improving care and advancing research toward a cure. In everything we do, we build on the energy, experience and passion of our global Parkinson's community. Since 1957, the Parkinson's Foundation has invested more than $425 million in Parkinson's research and clinical care. Connect with us on Parkinson.org, Facebook, Twitter, Instagram or call 1-800-4PD-INFO (1-800-473-4636).
Affecting an estimated one million Americans, Parkinson's disease is the second-most common neurodegenerative disease after Alzheimer's and is the 14th-leading cause of death in the U.S. It is associated with a progressive loss of motor control (e.g., shaking or tremor at rest and lack of facial expression), as well as non-motor symptoms (e.g., depression and anxiety). There is no cure for Parkinson's and nearly 90,000 new cases are diagnosed each year in the U.S.
MEDIA CONTACT:
Marissa Cruz
Parkinson's Foundation
[email protected]
305-537-9926
Parkinson.org
SOURCE Parkinson's Foundation
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
靶点
-
药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。